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Blade and balloon atrial septostomy has been used to reduce cardiopulmonary symp-
toms and as a bridge to lung or heart lung transplant in primary pulmonary hypertension.
Due to severe right atrial dilatation and resultant loss of anatomical landmarks, the
procedure is technically difficult, and the reported postprocedure mortality rate varies
between 5% and 50%. Among others, marked systemic desaturation and systemic
hypotension presumably secondary to an excessively large atrial septal defect have been
reported as causes of postprocedure death. We report a case where a novel intracardiac
catheter-based phased-array 5.5–10 MHz transducer with spectral and color-flow Dopp-
ler capabilities was used to assist a balloon atrial septostomy and to obtain hemody-
namic data in a patient with end-stage pulmonary hypertension. Cathet Cardiovasc
Intervent 2001;52:530–534. © 2001 Wiley-Liss, Inc.
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INTRODUCTION
Blade and balloon atrial septostomy has been used to
reduce cardiopulmonary symptoms and as a bridge to
lung or heart lung transplant in primary pulmonary hy-
pertension (PPH) [1–5]. Due to severe right atrial dila-
tation and resultant loss of anatomical landmarks, the
procedure is technically difficult, and the reported post-
procedure mortality rate varies between 5% and 50%
[1,2]. Among others, marked systemic desaturation and
systemic hypotension presumably secondary to an exces-
sively large atrial septal defect have been reported as
causes of postprocedure death [2].
Recent studies have demonstrated the utility of intra-
cardiac echocardiography (ICE) during cardiac interven-
tions, including electrophysiologic procedures and trans-
septal catheterizations [6–10]. We report the use of a
novel catheter-based ICE with full Doppler capability to
assist balloon atrial septostomy and to obtain Doppler-




A 46-year-old woman with NYHA class IV dyspnea
and right heart failure attributable to PPH was refractory
to therapy, including epoprostenol, diuretics, and
digoxin, and trials of intravenous dobutamine, dopamine,
and phenylephrine. Her heart rate ranged from 100 to
115, blood pressure of 78–84/40–50, and respiratory
rate of 20–22.
Right heart catheterization demonstrated a mean right
atrial pressure of 20 mm Hg, pulmonary artery pressure
of 84/40 mm Hg, decreased cardiac output at 3.5 l/m, and
markedly elevated pulmonary vascular resistance at 10.5
Wood units
A balloon atrial septostomy was suggested as a pallia-
tive procedure. Due to her poor clinical status and the
potential risks of the procedure, the possibility of trans-
esophageal echocardiographic (TEE) guidance was con-
idered. However, it was felt that the patient would not
h ve been able to tolerate the sedation needed for TEE
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guidance. It was therefore decided to perform the proce-
dure using a novel intracardiac ultrasound catheter.
Procedure
After obtaining informed consent and under a compas-
sionate Institutional Review Board approval, a 10 Fr
catheter with a phased-array 5.5–10 MHz transducer with
spectral and color-flow Doppler capabilities (AcuNav,
Acuson, Mountainview, CA) was inserted via the left
femoral vein and advanced under ultrasound imaging and
fluoroscopic guidance into the right atrium. The catheter
was connected to a standard Sequoia (Acuson) ultra-
sound platform. Images of the left atrium (LA), right
atrium (RA), and the atrial septum (IAS, white arrow in
Fig. 1) were obtained. Utilizing a Mullins sheath, a
Brockenbrough needle was inserted and after appropriate
positioning the septum was punctured under echocardio-
graphic guidance. A 10 mm3 20 mm Courier balloon
catheter (Meditech, Watertown, MA) was then advanced
through the septum over a 0.0380 Schneider valvulo-
plasty wire (Schneider, Minneapolis, MN). Two infla-
tions were performed at 6 atm. Color Doppler was used
to obtain hemodynamic data after each balloon inflation.
RESULTS
Images of the LA, RA, and IAS are shown in Figure
1A. Figure 1B shows the typical tenting of the IAS by the
Mullins sheath and the transseptal needle during ad-
vancement of the system. This appearance is indicative
of appropriate positioning of the Brockenbrough needle
against the interatrial septum. Advancement of the Mul-
lins sheath through the septum and inflation of the bal-
l on are shown in Figure 1C and D. The iatrogenic atrial
Fig. 1. A: Images of the left atrium (LA), right atrium (RA), the interatrial septum (IAS, white
arrow), and the aorta (AO). B: Typical tenting of the IAS by the Mullins sheath and the transseptal
needle during advancement of the system (white arrow). This appearance is indicative of
appropriate positioning of the Brockenbrough needle against the IAS. C: The Mullins sheath is
advanced through the septum (white arrow). D: Inflation of the balloon (white arrow).
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septal defect (ASD) is shown in Figure 2A. Color Dopp-
ler (Fig. 2B and C) revealed a moderate-size ASD with
continuous right-to-left flow. The baseline systemic ox-
ygen saturation was 92%; it decreased to 82% after the
second balloon inflation. Based on the intracardiac Dopp-
ler echocardiographic measurements, it was felt that the
size of the ASD (Fig. 3) was adequate and it was decided
not to perform additional balloon inflations. The postpro-
cedure course was uncomplicated, and the patient was
weaned off the Neo-synephrine. After hospital discharge,
at 2-month follow-up the patient was alive although still
with class IV symptoms.
DISCUSSION
The use of intracardiac echocardiography has been
limited by suboptimal imaging depth, large transducer
size with poor steerability, and lack of Doppler capabil-
ities. However, with the recent advent of lower-fre-
quency (5.5–12.5 MHz) ultrasound catheters with ex-
panded imaging ability and smaller size (6–10 Fr), the
safety and feasibility of ICE has been demonstrated
[11,12]. Among the many potential clinical applications
of ICE, its utility during electrophysiologic procedures
[7,8,10] and transseptal catheterization [6–9] has been
w ll established.
To our knowledge, this is the first report on using this
versatile, phased-array intracardiac catheter to image
anatomy and blood flow to guide atrial septostomy as a
palliative treatment for pulmonary hypertension. As
mentioned above, we used a 10 Fr catheter with a
phased-array 5.5–10 MHz transducer with full Doppler
capability. We did not encounter any problems with
catheter handling in the right atrium despite the 10 Fr size
because of the non–over-the-wire catheter design and its
steerable tip. The four-way tip articulation permitted
optimal transducer positioning. We obtained high-quality
images of the IAS, including the adjoining structures
such as the aorta (AO, Fig. 1A). Using the articulation
function, imaging of the IAS was optimized to guide the
Fig. 2. A: Iatrogenic atrial septal defect (ASD). B and C: Color Doppler flow through a moder-
ate-size ASD with continuous right-to-left flow. D: Tricuspid regurgitant velocity.
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needle away from the superior and inferior limbus and
toward the thin portion of the IAS. We were also able to
use color Doppler to assess the size of the ASD, visualize
right-to-left flow, and sample tricuspid velocity (3.56
m/sec) with the catheter. The assessment of the hemo-
dynamic significance of the ASD is particularly relevant
because the goal of the procedure is to create a right-to-
left shunt to increase left ventricular filling while avoid-
ing excessive systemic desaturation secondary to over-
sizing of the ASD. The current guidelines for balloon
atrial septostomy recommend as a target a post–balloon
dilatation oxygen saturation of 80%. However, there is
always the risk of exceeding this target with additional
balloon dilatations, and marked systemic desaturation
and systemic hypotension presumably secondary to an
excessively large atrial septal defect have been reported
as causes of postprocedure death. In the case described,
we elected not to perform further dilatations with a larger
balloon after intracardiac 2D and color Doppler echocar-
diography demonstrated the presence of a moderate-size
ASD with continuous right-to-left flow. Thus, we believe
that this modality allows an overall assessment of the
adequacy of the atrial septal defect and that it allows us
to avoid additional balloon inflations that could lead to
marked systemic oxygen desaturation. One limitation
that we encountered was difficulty in obtaining Doppler
velocity values of flow through the ASD, as it was almost
perpendicular to our cursor.
Although fluoroscopy was used to guide the ultra-
s und catheter and the septostomy apparatus, we believe
that with further experience, there is potential for this
catheter to be used without flouroscopy (if not needed for
other reasons at the same time). In one animal study,
Epstein et al. [13] has demonstrated the safety of ICE
with nonflouroscopic transseptal catheterization. More
recently, Ewert et al. [14] have described nonfluoro-
scopic transcatheter closure of atrial septal defects with
transesophageal echocardiographic guidance. We believe
hat ICE can be helpful in immediately identifying peri-
or postprocedural complications, and that it could be
used for guiding closure of atrial septal defects, for
guiding balloon mitral valvuloplasty, and for continu-
ously monitoring patients in an intensive care setting. In
addition, when compared with transesophageal echocar-
diography, intracardiac ultrasound imaging has a clinical
advantage related to the fact that it can be performed in
Fig. 3. Long-axis measurement of ASD size.
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unstable patients during interventional endovascular or
intracardiac procedures without the need of deep seda-
tion, and that it allows excellent resolution of intracardiac
structures with the patient in a supine position. Future
studies may help us in further defining these issues.
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